Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2008
10/23/2008US20080260784 Compositions and Methods for Modulating an Immune Response
10/23/2008US20080260783 Composition and method for controlling intestinal pathogenic organisms
10/23/2008US20080260782 Mycobacterium avium subspecies paratuberculosis vaccines and methods of using the same
10/23/2008US20080260781 Proteosome influenza vaccine
10/23/2008US20080260780 Materials and methods relating to improved vaccination strategies
10/23/2008US20080260779 Administering portcine circovirus type-2 antigen; therapy for infections such as lymphadenopathy, lymphoid depletion and nucxleation histocytes ; veterinary medicine
10/23/2008US20080260778 Bovine viral diarrhea virus; veterinary medicine
10/23/2008US20080260777 Antigen to stimulate immunology response in inoculated avian species; contains seven strains of Escherichia
10/23/2008US20080260776 Preparation of Salmonella Broad-Spectrum Vaccines
10/23/2008US20080260775 Modified Rna virus packaged with structural proteins and second virus; induce immunology response
10/23/2008US20080260774 Activation cytokine response in immune system including lymphocyte and antigen; anticancer agents; infection diseases; autoimmune disease; vaccine
10/23/2008US20080260773 Carrier protein containing t cell epitopes from pathogens conjugated to saccharide antigens
10/23/2008US20080260770 Use of Tellurium Compounds as Adjuvants
10/23/2008US20080260769 Protein comprising antigenic, oligomerization, transmembrane and adhesin domains; improving membrane surface expression of heterologous protein
10/23/2008US20080260768 Streptococcus pneumoniae proteins and nucleic acid molecules
10/23/2008US20080260767 Novel Protein Which can be Used, in Particular, for the In Vitro Isolation and Prevention of Legionella Pneumophila Infections
10/23/2008US20080260766 Epitopes, combined epitopes, use of epitopes or their combination, composition, uses of the composition, anti-HIV-1 prophylactic vaccines, therapeutic vaccines, method for the identification of epitopes and methods for treatment and prevention
10/23/2008US20080260765 Nucleotide sequences coding human papilloma viral early and late gene for use in developing vaccine for prevention and treatment of cervical cell proliferative disorders
10/23/2008US20080260764 Variation in viral replication peptide as evaluative tool in predicting virulence in emerging influenza strains
10/23/2008US20080260763 High Throughput Proteomics
10/23/2008US20080260762 HLA binding motifs and peptides and their uses
10/23/2008US20080260761 Compositions, Splice Variants and Methods Relating to Cancer Specific Genes and Proteins
10/23/2008US20080260760 Nucleotide sequences coding prostate-specific antigen-derived peptide for use as vaccine inntreatment of urogenital cell proliferative disorders
10/23/2008US20080260759 Novel Mite Allergen
10/23/2008US20080260758 Cell which expresses granulocyte colony stimulating factor and is deficient in major histocompatibility class I (MHC-I) antigens and major histocompatibility class II (MHC-II) antigens and which stimulates immune response to cancer
10/23/2008US20080260757 Bispecific Fusion Antibodies With Enhanced Serum Half-Life
10/23/2008US20080260756 Peptide Inhibitors of iASPP
10/23/2008US20080260755 Therapeutic fusion protein in which coagulation factor sequences are fused to half-life enhancing polypeptide for use in treatment of hemophilia
10/23/2008US20080260754 Prevent transplant rejection; autoimmune diseases
10/23/2008US20080260753 Transgenic animal model expressing NOD mutant for use in identifying modulator for treatment of inflammatory bowel disease
10/23/2008US20080260752 Prevention and reduction of blood loss
10/23/2008US20080260751 Using activator of toll like receptor-4 protein as therapeutic in treatment and prevention of arthritic, inflammatory, kidney, skin bone, respiratory, brain, cell proliferative and liver disorders
10/23/2008US20080260750 Polynucleotides Encoding Acetylcholine-Gated Chloride Channel Subunits of Caenorhabditis Elegans
10/23/2008US20080260749 Novel Tetrahydropyridothiophenes
10/23/2008US20080260748 Desmocollin 2 (DSC2) specific immunoglobulin for use in prevention and treatment of cell proliferative disorders
10/23/2008US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood
10/23/2008US20080260746 Erythropoietin polypeptide for use in treatment and prevention of viral, skin, nervous system, autoimmune, cardiovascular, kidney, cell proliferative and cardiovascular disorders
10/23/2008US20080260745 Targeted identification of immunogenic peptides
10/23/2008US20080260744 Using neuronal membrane protein receptor as screening tool in identifying modulators for treatment of brain disorders
10/23/2008US20080260743 Means and Methods for Detecting Methylated Dna
10/23/2008US20080260742 Preventives/Remedies for Cancer
10/23/2008US20080260741 Preventive and/or Therapeutic Agent for Cancer
10/23/2008US20080260740 Anti-LFL2 Antibodies for the Diagnosis, Prognosis and Treatment of Cancer
10/23/2008US20080260739 Use of Anti-Mortalin 2 Antibody and Functional Nucleic Acid for Cancer Therapies
10/23/2008US20080260738 Single chain fc, methods of making and methods of treatment
10/23/2008US20080260737 Using B Lymphocyte stimulator (BLyS) a ntagonist to decrease immunoglobulin levels in mammals; treating diabetes, multiple sclerosis and/or inflammatory bowel diseases
10/23/2008US20080260736 Using transforming growth factor modulators to regulate hepcidin expression and treat hemochromatosis
10/23/2008US20080260735 Glycoprotein-340 for use in targeted destruction of cancer tissues; immunotherapy
10/23/2008US20080260734 Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
10/23/2008US20080260733 Humanized collagen antibodies and related methods
10/23/2008US20080260732 Integrin specific immunoglobulin for inhibiting vascularization and treating cell proliferative disorders
10/23/2008US20080260731 Fc gamma RIIIa receptor specific immunoglobulin comprising reduced fucose mdoification for use in treatment and prevention of cell proliferative and autoimmune diseases
10/23/2008US20080260730 Using cytokine specific immunoglobulin for treatment and prevention of inflammatory, skin and autoimmune disorders
10/23/2008US20080260729 Using RNA interference and/or endothelial growth factor specific immunoglobulins to target, treat and prevent cell proliferative disorsders
10/23/2008US20080260728 Using very late antigen-4 (VLA-4) specific immunoglobulins for prevention and treatment of autoimmune diseases
10/23/2008US20080260727 Modulation of Nkg2d
10/23/2008US20080260726 Using cathepsin C gene expression as evaluative tool in identifying modulators for prevention and treatment of inflammatory or obstructive diseases of the respiratory system
10/23/2008US20080260725 Tag and target delivery system
10/23/2008US20080260724 Using pattern recognition receptor specific immunoglobulin to target and treat fungal infection
10/23/2008US20080260723 Method of Treatment and Bioassay Involving Macrophage Migration Inhibitory Factor (MIF) as Cardiac-Derived Myocardial Depressant Factor
10/23/2008US20080260722 Nutrient broth comprising neurotrophins for use in propgation of nervous system tissues; tissue engineering and repair; regenerative medicine
10/23/2008US20080260721 Nucleotide sequences coding regulatory-associated protein of mTOR (Raptor) protein for use in identifying modulators for prevention and treatment of cancer and diabetes
10/23/2008US20080260720 Systems and Methods for Inhibiting Metastasis
10/23/2008US20080260719 EDG: Modulators of lymphocyte activation and migration
10/23/2008US20080260718 Phospholipase C Gamma Modulation and Uses Thereof for Management of Pain and Nociception
10/23/2008US20080260717 Methods for Reducing Seizure-Induced Neuronal Damage
10/23/2008US20080260701 Cytokine induced killer cell populations for use in treatment of cell proliferative disordersl; tissue engineering and repair; tissue targeted therapy
10/23/2008US20080260698 Chimeric sindbis-western equine encephalitis virus and uses thereof
10/23/2008US20080260689 Mixture comprising Interleukin receptor amino acid sequences for use in developing vaccine for prevention and treatment of autoimmune diseases; genetic vaccines
10/23/2008US20080260688 Imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
10/23/2008US20080260685 Prodrugs of cc-1065 analogs
10/23/2008US20080260680 Method of Attenuating Reactions to Skin Irritants
10/23/2008US20080260641 Isolated human monoclonal antibodies which bind to lymphocyte function associated antigens; therapy and diagnosis methods; skin disorders; antiarthritic agents; inflammatory bowel disease
10/23/2008US20080260635 Mediation of cytotoxicity of tumor cells; using cancer disease modifying antibodies and drugs; initiating cytotoxic response; binding analysis
10/23/2008CA2718573A1 Targeting abcb5 for cancer therapy
10/23/2008CA2688693A1 Interferons of rhesus and cynomolgus origin and uses thereof
10/23/2008CA2684494A1 Fusion protein vaccine
10/23/2008CA2684392A1 Milk derived antigen specific antibodies, methods of preparation and uses thereof
10/23/2008CA2684103A1 Delivery of flu antibodies to surfaces in contact with air
10/23/2008CA2683916A1 Vaccine
10/23/2008CA2683778A1 Prevention of staphylococcus biofilm formation
10/23/2008CA2683772A1 New virulence factors of streptococcus pneumoniae
10/23/2008CA2683752A1 Method of inducing neutralizing antibodies to human immunodeficiency virus
10/23/2008CA2683629A1 Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods
10/23/2008CA2683559A1 Methods for treating cancer resistant to erbb therapeutics
10/23/2008CA2683454A1 Tem8 peptides and vaccines comprising the same
10/23/2008CA2682870A1 Tuberculosis vaccine and method of using same
10/23/2008CA2682730A1 Use of an inhibitor of tnf.alpha. plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
10/23/2008CA2671540A1 Linear expression cassette vaccines
10/23/2008CA2664783A1 Methods for treating, preventing and diagnosing porcine ttv infection
10/22/2008EP1983055A1 Albumin fusion proteins
10/22/2008EP1983047A1 Novel viral vector
10/22/2008EP1983001A2 Antibodies to mammalian Langerhans cell antigen and their uses
10/22/2008EP1983000A2 Method for the treatment of multiple sclerosis by inhibiting IL-17 activity
10/22/2008EP1982999A1 Milk derived antigen specific antibodies, methods of preparation and uses thereof
10/22/2008EP1982729A1 Vaccination Regimen for B-Cell Vaccines
10/22/2008EP1982728A1 Peptide derived from hepatitis c virus
10/22/2008EP1982727A1 Method for purification of viral proteins
10/22/2008EP1982726A1 Novel vaccine carrier
10/22/2008EP1982725A1 Method or agent for inhibiting the function of efflux pump of pseudomonas aeruginosa
1 ... 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 ... 1823